Please login to the form below

Not currently logged in
Email:
Password:

Ron Menezes joins Almirall’s Aqua Pharmaceuticals

He joins the US dermatology group as its president and general manager

Amirall's US dermatology company Aqua Pharmaceuticals has appointed Ron Menezes as its new president and general manager.

Menezes joins the group from Depomed Pharmaceuticals, where he served as vice president of sales and sales operations, pain and CNS.

Prior to his role at Depomed, Menezes was at Allergan in senior roles including vice president sales and marketing, medical dermatology and he has also held positions at Abbott, Astellas and Pfizer.

Eduardo Sanchiz, chief executive officer at Almirall, said: “We are very pleased to announce the appointment of Ron Menezes as the new president and GM of Aqua Pharmaceuticals.

“Ron’s incorporation and he experience he brings in dermatology represent a clear and undeniable opportunity to further strengthen this organisation.”

Menezes will replace Ted White, who has been president and general manager of Aqua Pharmaceuticals since January 2016.

Sanchiz added: “Almirall continues to consider Aqua as a very important platform in the US market to support existing and new products.”

Aqua Pharmaceuticals was acquired by the Spanish group back in 2013 - a deal that was worth around $400m - to access the US dermatology market.

23rd August 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....